RPG Life Sciences Limited
Revenue of ₹666 Cr in FY2025.
Data-driven analysis for 403+ Indian stocks
Revenue of ₹666 Cr in FY2025.
Revenue of ₹1,257 Cr in FY2025.
Revenue grew 20.3% to ₹47,505 Cr in FY2024.
Revenue declined 10.9% to ₹2,279 Cr in FY2025.
Revenue grew 15.5% to ₹1,14,220 Cr in FY2025.
Revenue declined 30.4% to ₹2,030 Cr in FY2024.
Revenue grew 28.2% to ₹1,946 Cr in FY2020.
Revenue compounded at 17.7% annually over 10 years.
Revenue declined 50.1% to ₹171 Cr in FY2025.
Revenue grew 45.9% to ₹258 Cr in FY2025.
Turned profitable with net income of ₹32.3 Cr in FY2025.
Reported a net loss of ₹84.5 Cr in FY2025.
Revenue of ₹1,286 Cr in FY2025.
Revenue of ₹5,606 Cr in FY2025.
Revenue of ₹19,283 Cr in FY2025.
Revenue grew 15.5% to ₹23,165 Cr in FY2024.
Revenue of ₹5,043 Cr in FY2025.
Revenue grew 29.4% to ₹4,163 Cr in FY2025.
Revenue grew 17.0% to ₹10,228 Cr in FY2025.
Revenue declined 21.4% to ₹5,326 Cr in FY2025.
Revenue of ₹14,826 Cr in FY2025.
Revenue of ₹6,63,343 Cr in FY2025.
Revenue of ₹1,03,354 Cr in FY2025.
Revenue declined 27.8% to ₹3,996 Cr in FY2025.
Use our fundamental analysis tools and financial data to make informed investment decisions.